Drug harms in the UK: a multicriteria decision analysis
- PMID: 21036393
- DOI: 10.1016/S0140-6736(10)61462-6
Drug harms in the UK: a multicriteria decision analysis
Abstract
Background: Proper assessment of the harms caused by the misuse of drugs can inform policy makers in health, policing, and social care. We aimed to apply multicriteria decision analysis (MCDA) modelling to a range of drug harms in the UK.
Methods: Members of the Independent Scientific Committee on Drugs, including two invited specialists, met in a 1-day interactive workshop to score 20 drugs on 16 criteria: nine related to the harms that a drug produces in the individual and seven to the harms to others. Drugs were scored out of 100 points, and the criteria were weighted to indicate their relative importance.
Findings: MCDA modelling showed that heroin, crack cocaine, and metamfetamine were the most harmful drugs to individuals (part scores 34, 37, and 32, respectively), whereas alcohol, heroin, and crack cocaine were the most harmful to others (46, 21, and 17, respectively). Overall, alcohol was the most harmful drug (overall harm score 72), with heroin (55) and crack cocaine (54) in second and third places.
Interpretation: These findings lend support to previous work assessing drug harms, and show how the improved scoring and weighting approach of MCDA increases the differentiation between the most and least harmful drugs. However, the findings correlate poorly with present UK drug classification, which is not based simply on considerations of harm.
Funding: Centre for Crime and Justice Studies (UK).
Copyright © 2010 Elsevier Ltd. All rights reserved.
Comment in
-
Ranking of drugs: a more balanced risk-assessment.Lancet. 2010 Nov 6;376(9752):1524-5. doi: 10.1016/S0140-6736(10)62000-4. Epub 2010 Oct 29. Lancet. 2010. PMID: 21036391 No abstract available.
-
Drugs and harm to society.Lancet. 2011 Feb 12;377(9765):551-2; author reply 555. doi: 10.1016/S0140-6736(11)60193-1. Lancet. 2011. PMID: 21315936 No abstract available.
-
Drugs and harm to society.Lancet. 2011 Feb 12;377(9765):551; author reply 555. doi: 10.1016/S0140-6736(11)60192-X. Lancet. 2011. PMID: 21315937 No abstract available.
-
Drugs and harm to society.Lancet. 2011 Feb 12;377(9765):552; author reply 555. doi: 10.1016/S0140-6736(11)60194-3. Lancet. 2011. PMID: 21315938 No abstract available.
-
Drugs and harm to society.Lancet. 2011 Feb 12;377(9765):552-3; author reply 555. doi: 10.1016/S0140-6736(11)60195-5. Lancet. 2011. PMID: 21315939 No abstract available.
-
Drugs and harm to society.Lancet. 2011 Feb 12;377(9765):553-4; author reply 555. doi: 10.1016/S0140-6736(11)60196-7. Lancet. 2011. PMID: 21315940 No abstract available.
-
Drugs and harm to society.Lancet. 2011 Feb 12;377(9765):554; author reply 555. doi: 10.1016/S0140-6736(11)60197-9. Lancet. 2011. PMID: 21315941 No abstract available.
-
Drugs and harm to society.Lancet. 2011 Feb 12;377(9765):554; author reply 555. doi: 10.1016/S0140-6736(11)60198-0. Lancet. 2011. PMID: 21315942 No abstract available.
-
Questioning the method and utility of ranking drug harms in drug policy.Int J Drug Policy. 2011 Jul;22(4):243-6. doi: 10.1016/j.drugpo.2011.04.004. Epub 2011 Jun 8. Int J Drug Policy. 2011. PMID: 21652195
Similar articles
-
The Australian drug harms ranking study.J Psychopharmacol. 2019 Jul;33(7):759-768. doi: 10.1177/0269881119841569. Epub 2019 May 13. J Psychopharmacol. 2019. PMID: 31081439
-
European rating of drug harms.J Psychopharmacol. 2015 Jun;29(6):655-60. doi: 10.1177/0269881115581980. Epub 2015 Apr 28. J Psychopharmacol. 2015. PMID: 25922421
-
Development of a rational scale to assess the harm of drugs of potential misuse.Lancet. 2007 Mar 24;369(9566):1047-53. doi: 10.1016/S0140-6736(07)60464-4. Lancet. 2007. PMID: 17382831 Review.
-
Multicriteria decision analysis (MCDA) for health technology assessment: the Queensland Health experience.Aust Health Rev. 2019 Oct;43(5):591-599. doi: 10.1071/AH18042. Aust Health Rev. 2019. PMID: 30205873
-
The children of mama coca: coca, cocaine and the fate of harm reduction in South America.Int J Drug Policy. 2007 Mar;18(2):99-106. doi: 10.1016/j.drugpo.2006.11.017. Epub 2007 Jan 5. Int J Drug Policy. 2007. PMID: 17689352 Review.
Cited by
-
Bad habits-good goals? Meta-analysis and translation of the habit construct to alcoholism.Transl Psychiatry. 2024 Jul 19;14(1):298. doi: 10.1038/s41398-024-02965-1. Transl Psychiatry. 2024. PMID: 39030169 Free PMC article. Review.
-
Quantifying alcohol's harm to others: a research and policy proposal.Bull World Health Organ. 2024 Jun 1;102(6):448-452. doi: 10.2471/BLT.24.291338. Epub 2024 Apr 30. Bull World Health Organ. 2024. PMID: 38812799 Free PMC article.
-
Primary, Secondary, and Tertiary Prevention of Substance Use Disorders through Socioecological Strategies.NAM Perspect. 2023 Sep 6;2023:10.31478/202309b. doi: 10.31478/202309b. eCollection 2023. NAM Perspect. 2023. PMID: 38784638 Free PMC article. Review. No abstract available.
-
A thematic analysis of MDMA-related harm and harm reduction experiences and knowledge in Aotearoa New Zealand.Harm Reduct J. 2024 May 23;21(1):100. doi: 10.1186/s12954-024-01024-8. Harm Reduct J. 2024. PMID: 38783300 Free PMC article.
-
Variants of the P3 event-related potential operate as indicators of distinct mechanisms contributing to problematic alcohol use.Neuropsychopharmacology. 2024 May 11. doi: 10.1038/s41386-024-01874-7. Online ahead of print. Neuropsychopharmacology. 2024. PMID: 38734817
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous